ETFS Holding Actavis Inc

 
ETF Quotes for ETFS Holding Actavis Inc top ^
  • Holdings: Johnson & Johnson , Pfizer Inc , Merck & Co Inc , Bristol-Myers Squibb Company , Actavis PLC ,
  • Morningstar Rating: 4 Stars
Sign-up for ihe investment picks
  • Holdings: Exelon Corp , Actavis PLC , Exxon Mobil Corporation , Qualcomm Inc , Baxter International Inc ,
Sign-up for moat investment picks
  • Holdings: Regeneron Pharmaceuticals Inc , Medivation Inc , Idexx Laboratories , Actavis PLC , Cooper Companies ,
  • Morningstar Rating: 2 Stars
Sign-up for pth investment picks
  • Holdings: American Airlines Group Inc , Burlington Stores Inc , Delta Air Lines Inc , Actavis PLC , CDW Corp ,
Sign-up for guru investment picks

 
News Articles for Actavis Inc top ^
DUBLIN , Oct.
Sign-up for Actavis Confirms Appeals Court Upholds Lo Loestrin® Fe Patent investment picks
DUBLIN , Nov.
Sign-up for Actavis Announces Planned Retirement of R. Todd Joyce in Early 2015 investment picks
- Increases Second Half Non-GAAP EPS Forecast to $6.60-$6.70 - - 158% Increase in Third Quarter 2014 Adjusted EBITDA to $1.3 billion - - North American Brands Revenues of $1.6 billion; North American Generics and International Revenues of $1.6 billion - - Debt Repayment of ~$750 million During Quarter - - Business Development Initiatives Expand Portfolios; Significant Progress in Integration/Synergy Capture - - GAAP Loss Per Diluted Share in Third Quarter of $3.95 - DUBLIN , Nov.
Sign-up for Actavis Net Revenue Increases 83% to $3.7 Billion in Third Quarter 2014; Non-GAAP EPS Increases 53% to $3.19 investment picks
DUBLIN and CHICAGO , Oct.
Sign-up for Actavis and Durata Therapeutics Receive U.S. FTC Clearance for Actavis' Proposed Acquisition of Durata investment picks
- Expertise in global finance, M&A, business development - - Will join Actavis effective December 8, 2014 - DUBLIN , Nov.
Sign-up for Actavis Names Maria Teresa Hilado Chief Financial Officer investment picks
Levi & Korsinsky is investigating the Board of Directors of Allergan Inc. (“Allergan” or “the Company”) (NYSE: AGN) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Actavis plc.
Sign-up for AGN INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of Allergan Inc. in Connection With the Fairness of the Sale of the Company to Actavis plc investment picks
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Allergan, Inc. (“Allergan”) (NYSE: AGN) concerning the acquisition by Actavis.
Sign-up for ALLERGAN SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Actavis investment picks
By Jonathan D.
Sign-up for Actavis to buy Allergan in $66 billion deal investment picks
- Transaction Valued at $66 Billion or $219 per Share in Cash and Actavis Shares - - Fastest Growing, Most Dynamic Pharmaceutical Company in Global Healthcare - - Leading Blockbuster Franchises in Ophthalmology, Neurosciences/CNS, Medical Aesthetics/Dermatology/Plastic Surgery, Women's Health, Gastroenterology and Urology - - Positioned for Long-Term Double-Digit Organic Revenue and Earnings Growth - - Double-Digit Accretion to Non-GAAP EPS within First 12 Months - - Expands International Presence with Greater Market and Product Reach - - Projected Synergies of at Least $1.8 Billion while Maintaining R&D Commitment of Approximately $1.7 Billion - - Free Cash Flow Generation of more than $8 Billion expected in 2016 - - Investment Grade Rating Expected to be Maintained; Rapid Deleveraging to Below 3.5x Debt to Adjusted EBITDA within 12 Months - - Closing Anticipated in Q2 2015 - DUBLIN and IRVINE, Calif.
Sign-up for Actavis to Acquire Allergan to Create Top 10 Global Growth Pharmaceutical Company with $23 Billion in Revenue investment picks
By Jonathan D.
Sign-up for Actavis, Allergan close to a deal investment picks
Botox maker Allergan Inc. (AGN) and Irish pharmaceutical company Actavis PLC (ACT) are close to a friendly deal, which could be announced as early as Monday, the Wall Street Journal reported Sunday.
Sign-up for Allergan, Actavis near cash-and-stock deal: WSJ investment picks
Levi & Korsinsky is investigating the Board of Directors of Allergan Inc. (“Allergan” or “the Company”) (NYSE:AGN) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Actavis plc.
Sign-up for AGN SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Allergan Inc. in Connection With the Fairness of the Sale of the Company to Actavis plc investment picks
By Russ Britt, MarketWatch Actavis shares jump 5.5% while Allergan rises 1.4% LOS ANGELES (MarketWatch) -- This has got to be a new one in the merger game: the buyer's shares have gone up more than the company it's buying.
Sign-up for Actavis shares outpace buyout target's gains investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
ETFS Holding Actavis Inc
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: ETFS Holding ACI Worldwide, Inc.  |  Next: ETFS Holding Actavis PLC